Introduction {#s1}
============

Venezuelan equine encephalitis virus (VEEV) is the most important alphaviral (*Togaviridae*: *Alphavirus*) pathogen of humans and domestic animals in the western hemisphere [@pntd.0000472-Weaver1],[@pntd.0000472-Walton1]. Most human and animal disease occurs when VEEV undergoes an amplification cycle where equids (horses, donkeys and mules) become infected and develop high titer viremia, facilitating transmission by *Aedes* and *Psorophora* spp. mosquitoes to susceptible equids or people. The VEEV strains involved in this equid amplification cycle belong to subtypes IAB and IC, and are called epizootic or epidemic (henceforth called epidemic). These strains arise periodically and repeatedly via mutation of enzootic VEEV subtypes [@pntd.0000472-Powers1]. The resulting epidemics typically involve tens-to-hundreds of thousands of cases in humans and equids. Human disease is highly debilitating and immunosuppressive, and occasionally fatal (less than 1% of cases); however, many persons, especially children, suffer permanent neurological sequelae [@pntd.0000472-Walton1],[@pntd.0000472-Johnson1]. In equids, VEEV causes mortality in roughly half of infected animals, resulting in major effects on agricultural activities that rely on these animals in many parts of Latin America.

The progenitors of the epidemic VEEV strains are called enzootic viruses, are not associated with equine disease, and circulate more or less continuously in forested or swamp habitats where rodents serve as the reservoir hosts and mosquitoes in the subgenus *Culex* (*Melanoconion*) act as vectors [@pntd.0000472-Anishchenko1]. These enzootic strains were first isolated in the 1950\'s, and a fatal human isolate made in Panama in 1961 [@pntd.0000472-Johnson2] was later identified as a subtype ID enzootic strain. The enzootic VEEV cycle, which involves subtypes ID and IE, often goes undetected because these viruses are incapable of exploiting these hosts for amplification to produce widespread disease [@pntd.0000472-Walton1],[@pntd.0000472-Johnson1]. However, enzootic VEEV strains are increasingly recognized as important endemic pathogens of people who live near the enzootic transmission foci and/or enter the habitats where enzootic circulation occurs [@pntd.0000472-Johnson1],[@pntd.0000472-Johnson3],[@pntd.0000472-Aguilar1]. Because human VEE is nearly impossible to distinguish clinically from other tropical viral diseases such as dengue, most cases are probably undiagnosed. Endemic VEE is therefore grossly underreported in many parts of the Americas where enzootic circulation occurs and surveillance for febrile illness is limited.

To further characterize human disease caused by enzootic VEEV, we studied 42 cases of VEEV infection characterized by virus isolation, some accompanied by neurological disease, detected in Panama from 1961--2004. Here we describe the clinical signs and symptoms of disease, ecological conditions accompanying VEEV exposure and genetic characterizations of the etiologic VEEV strains.

Methods {#s2}
=======

Virus isolates {#s2a}
--------------

VEEV isolates from infected persons, included in the study, are shown in [Table 1](#pntd-0000472-t001){ref-type="table"}. The retrospective analyses of these isolates and reporting of clinical data were approved by the Institutional Review Boards of the Gorgas Memorial Institute and the University of Texas Medical Branch. Most of the viruses were isolated in Vero cells or by intracerebral inoculation of newborn mouse brains with sera from febrile patients, with triturated mosquito pools, or with rodent tissues (approved by the institutional animal care and use committees of the Gorgas Memorial Institute and the University of Texas Medical Branch). Supernatant fluids from infected cells or brain homogenates were stored at −70°C and later used for the extraction of viral RNA.

10.1371/journal.pntd.0000472.t001

###### Venezuelan equine encephalitis virus isolates from humans, mosquitoes and rodents included in the study.

![](pntd.0000472.t001){#pntd-0000472-t001-1}

  Strain         GenBank Acc. No.[\*](#nt101){ref-type="table-fn"}     Location (Province, site)      Year of isolation     Host     Age (Years)[\*\*](#nt102){ref-type="table-fn"}       Passage history       Signs and symptoms[\*\*\*](#nt103){ref-type="table-fn"}
  ------------- --------------------------------------------------- -------------------------------- ------------------- ---------- ------------------------------------------------ ------------------------- ---------------------------------------------------------
  4840                               FJ969477                                    Panama                     1961           Human                        unknown                       BHK-1, SMB-2,V-1, CEC-1                           unknown
  BT-2607                            AF004450                          Bocas del Toro, Almirante            1961          Mosquito                         NA                                ?, BHK-1                                     NA
  3880                L00930[\*](#nt101){ref-type="table-fn"}                Panama, Cañito                 1961           Human                           14                               SMB-2, V-2          1, 2, 4, 5, 10, 19[\*\*\*](#nt104){ref-type="table-fn"}
  8137                U88634[\*](#nt101){ref-type="table-fn"}                  El Rincón                    1962           Human                        unknown                             SMB-1, V-1                                  unknown
  8138                               FJ969478                                  El Rincón                    1962           Human                        unknown                                CEC-2                                    unknown
  8585                               FJ969479                                  El Rincón                    1962           Human                        unknown                               Unknown                                   unknown
  202330              U88635[\*](#nt101){ref-type="table-fn"}                Panama, Gamboa                 1963           Rodent                          NA                               SMB-1, V-2                                    NA
  P. Quintero         U88636[\*](#nt101){ref-type="table-fn"}              Panama, Juan Mina                1964           Human                        unknown                             CEC-1, V-1                                  unknown
  F-322               U88638[\*](#nt101){ref-type="table-fn"}                Panama, Cañito                 1965            N.K.                        unknown                               Unknown                                   unknown
  240832              U88637[\*](#nt101){ref-type="table-fn"}                Panama, Gamboa                 1965            N.K.                        unknown                             CEC-1, V-1                                  unknown
  MARU23283                          FJ969485                                Panama, Bayano                 1977           Human                        unknown                               Unknown                                   unknown
  GML903104           U88639[\*](#nt101){ref-type="table-fn"}                Panama, Bayano                 1977          Mosquito                         NA                                 Unknown                                     NA
  MARU29136                          FJ969469                             Panama, Alto de Jobo              1981           Human                        unknown                               Unknown                                   unknown
  GML903837                          FJ969476                                Panama, Bayano                 1984          Mosquito                      unknown                               Unknown                                   unknown
  GML903843           U88640[\*](#nt101){ref-type="table-fn"}                Panama, Bayano                 1984          Mosquito                      unknown                             V-1, BHK-1                                  unknown
  487317                             FJ969467                              Veraguas Santiago                1990           Human                           47                                   V-3                                      1, 2
  489243                             FJ969474                        Panama, San Miguelito Chilibre         1991           Human                          \>15                                  V-4                             1, 2, 3, 4, 5, 6, 7, 8
  93P1513             U88641[\*](#nt101){ref-type="table-fn"}              Panama, Lake Gatun               1993           Human                           27                               SMB-1, V-1                                  unknown
  489245                             FJ969472                              Panama, Felipillo                1995           Human                           21                                   V-4                                     1, 2, 3
  489246                             FJ969470                               Cocle, Aguadulce                1995           Human                           24                                   V-4                                     1, 2, 9
  489247                             FJ969471                              Panama, Felipillo                1996           Human                          \>15                                  V-4                                    1, 9, 10
  474590                             FJ969449                              Panama, Mananitas                1997           Human                           16                                   V-2                             1, 2, 3, 9, 11, 12, 16
  487315                             FJ969463                              Panama, Felipillo                1997           Human                           28                                   V-3                         1, 2, 3, 4, 5, 6, 9, 10, 11, 13
  487308                             FJ969457                                Darien, Sambu                  1998           Human                           10                                   V-2                                 1, 2, 3, 4, 11
  487309                             FJ969458                                Darien, Sambu                  1998           Human                           16                                   V-2                                   1, 2, 9, 11
  487310                             FJ969459                                Darien, Sambu                  1998           Human                           15                                   V-3                                 1, 2, 9, 11, 13
  487311                             FJ969460                                Darien, Sambu                  1998           Human                           9                                    V-3                                    1, 2, 11
  487312                             FJ969461                                Darien, Sambu                  1998           Human                           23                                   V-3                                   1, 2, 4, 10
  487313                             FJ969462                                Darien, Sambu                  1998           Human                           39                                   V-3                                  1, 9, 10, 11
  487314                             FJ969466                                Darien, Sambu                  1998           Human                           18                                   V-3                                    1, 2, 10
  481460                             FJ969450                              Panama, Felipillo                2000           Human                           16                                   V-2                                        1
  484551                             FJ969451                              Darien, R Iglesias               2001           Human                           15                                   V-2                                        1
  484918                             FJ969452                                Darien, Yaviza                 2001           Human                           5                                    V-2                                        1
  485028                             FJ969453                                Darien, Yaviza                 2001           Human                           9                                    V-2                                        1
  485029                             FJ969454                                Darien, Yaviza                 2001           Human                           9                                    V-2                                        1
  485030                             FJ969455                                Darien, Yaviza                 2001           Human                           3                                    V-2                                        1
  489242                             FJ969475                              Darien, R Iglesias               2001           Human                           10                                   V-3                                        1
  487321                             FJ969465                                Darien, Yaviza                 2001           Human                           5                                    V-3                                  1, 5, 15, 19
  486729                             FJ969456                                Darien, Meteti                 2002           Human                           20                                   V-1                                1, 2, 3, 4, 5, 6
  212857                             FJ969484                               Darien, Santa Fe                2003           Human                           10                                  SMB-1                                1, 2, 3, 5, 14
  212863                             FJ969480                               Darien, Santa Fe                2003           Human                           2                                   SMB-1                                     1, 5
  212908                             FJ969482                               Darien, Santa Fe                2003           Human                           15                                  SMB-1                              1, 2, 4, 11, 14, 17
  213391                             FJ969483                           Bocas del Toro, Guabito             2003           Human                           13                                  SMB-1                                    16, 18
  213413                             FJ969481                                Panama, Pacora                 2003           Human                           26                                  SMB-1                                1, 2, 3, 10, 11
  490021                             FJ998042                               Panama, El Cacao                2004           Human                           12                                 unknown                                     16
  490006                             FJ998043                             Panama, La Trinidad               2004           Human                           12                                 unknown                                      1
  489607                             FJ998044                                Colon, Escobal                 2004           Human                           48                                 unknown                                      1

**\*:** Sequence determined previously.

**\*\*:** NA = not applicable.

**\*\*\*:** 1 = Fever; 2 = headache, 3 = tremors; 4 = nausea; 5 = vomiting; 6 = diarrhea; 7 = rash; 8 = renal/hepatic failure; 9 = arthralgia; 10 = myalgia; 11 = retroorbital pain; 12 = exanthema; 13 = sore throat; 14 = back pain; 15 = convulsion; 16 = encephalitis; 17 = cough; 18 = hemorrhage; 19 = fatal.

**\*\*\*:** Data previously reported by Johnson et al. [@pntd.0000472-Johnson2].

Plaque assays {#s2b}
-------------

To determine the viremia levels in infected patients, available sera were tested by plaque assay as previously described [@pntd.0000472-Powers2] using Vero cells.

Viral RNA extraction and cDNA synthesis {#s2c}
---------------------------------------

RNA was extracted from virus stocks as described previously [@pntd.0000472-Weaver2]. A 250 µl volume of the 10% homogenized mouse brain tissue or supernatant was mixed with 750 µl of Trizol LS (Gibco-BRL, Gaithersburg, MD) and RNA was extracted following the manufacturer\'s protocol. Synthesis of cDNA was performed by mixing 5 µl of the RNA (1/10^th^ of the extracted RNA) with 1 µmol of reverse primer V9207B(−), 1× First Strand Buffer (Gibco), 1 mM dNTPs, 80 U RNAsin (Promega, Madison, WI) and 200 U SuperScript II Reverse Transcriptase (Gibco). The reaction was incubated at 42°C for 1 h.

PCR amplification, sequencing and phylogenetic analysis {#s2d}
-------------------------------------------------------

PCR was carried out using primers V8369(+) (GAGAACTGCGAGCAATGGTCA) and V9207B(−) (TRCACTGGCTGAACTGTT) as previously described [@pntd.0000472-Aguilar1]. These primers amplify the N-terminus of the PE2 envelope glycoprotein precursor gene, a region that has been used extensively in VEEV phylogenetic analyses [@pntd.0000472-Aguilar1],[@pntd.0000472-Oberste1],[@pntd.0000472-Watts1] and is known to undergo critical amino acid substitutions associated with epidemic VEEV emergence [@pntd.0000472-Weaver2]. The 816 bp PCR product was sequenced directly using primers V8659 (AATTGAGGCAGTGAAGAGCGAC) and V8953B (CTGCCTACAGGATTAAAT) using an Applied Biosystems (Foster City, CA) Prism automated DNA sequencing kit following the manufacturer\'s protocol. Sequences were aligned using MacVector program (Oxford Molecular Group, Campbell, CA) and phylogenetic analyses were performed using the maximum parsimony and neighbor joining programs implemented in the PAUP 4.0 software [@pntd.0000472-Swofford1] or with MrBayes 3.0 [@pntd.0000472-Ronquist1] with 1,000,000 iterations. Bootstrap analyses were conducted using neighbor joining with 1,000 replicates to place confidence values on grouping within the trees [@pntd.0000472-Felsenstein1].

Results {#s3}
=======

Distribution of the VEEV cases in Panama {#s3a}
----------------------------------------

Data from recent VEE cases we studied (1990--2004) were compared with those from the literature dating to 1961. Recent VEE cases in Panama were reported in the provinces of Darien, Panama, Cocle, Veraguas and Bocas del Toro ([Figure 1](#pntd-0000472-g001){ref-type="fig"}). Two clusters of cases were observed - one covering the Darien province and the second covering Panama Province (central Panama). Darien, the largest and most sparsely populated of the regions, extends from the hinterlands of Panama Province to the Colombian border, comprising more than one-third of the national territory. The land in Darien is characterized by forest and swamps and thus includes large areas of habitat for the *Culex* (*Melanoconion*) vectors of enzootic VEEV and small rodents that serve as the principal reservoir host [@pntd.0000472-Salas1]. The second cluster of cases was observed in Panama Province, between Gatun and Bayano Lakes. The surrounding area is characterized by rainforest and swamps habitats and is also conducive to enzootic VEEV circulation [@pntd.0000472-Johnson2],[@pntd.0000472-Franck1],[@pntd.0000472-Dietz1],[@pntd.0000472-Mangiafico1]. Cases of VEE in Panama were reported in patients whose age ranged from 10 months to 48 years old. The more severe cases with neurological complications were observed in children.

![Map of Panama showing the locations of the Venezuelan equine encephalitis cases.](pntd.0000472.g001){#pntd-0000472-g001}

Description of the VEE cases {#s3b}
----------------------------

The VEE cases we studied, as well as those previously reported and included here for comparative purposes, were characterized by fever, headache, tremors, nausea, vomiting and diarrhea ([Table 1](#pntd-0000472-t001){ref-type="table"}). Only 3 of the cases developed neurological complications, and 2 of these were fatal. All cases of neurological disease were children less than 15 years of age. Overall, the most common signs and symptoms among the 33 VEE patients for which data were available included fever (94%), headache (55%), retroorbital pain (27%) and tremors (27%)([Table 2](#pntd-0000472-t002){ref-type="table"}). These common signs and symptoms would not distinguish VEE from a wide variety of other tropical diseases, including malaria and dengue, without laboratory diagnostics. The overall case fatality rate of the Panamanian cases with known outcomes was 2/39, or 5% ([Table 1](#pntd-0000472-t001){ref-type="table"}). This rate is higher than that reported during most VEE epidemics (typically less than 1%) [@pntd.0000472-Smith1], which could reflect greater recognition of milder cases when more active surveillance is being conducted during outbreaks.

10.1371/journal.pntd.0000472.t002

###### Clinical signs and symptoms in 33 cases of Venezuelan equine encephalitis evaluated in Panama from 1961--2004.

![](pntd.0000472.t002){#pntd-0000472-t002-2}

  Sign/symptom             \% of patients exhibiting
  ----------------------- ---------------------------
  Fever                               94
  Headache                            55
  Retroorbital pain                   27
  Tremors                             27
  Nausea                              21
  Vomiting                            21
  Arthralgia                          21
  Myalgia                             21
  Diarrhea                             9
  Encephalitis                         9
  Sore throat                          6
  Back pain                            6
  Rash                                 3
  Renal/hepatic failure                3
  Exanthema                            3
  Convulsions                          3
  Cough                                3
  Hemorrhage                           3
  Fatality                             6

Viremia titers {#s3c}
--------------

To investigate whether humans infected with subtype ID enzootic VEEV develop viremia titers sufficient to infect potential mosquito vectors, we quantified the virus titers in the sera of 5 patients (the only ones from which virus was isolated that were still available) using plaque assay. Titers varied from 3.0×10^2^ to 6.7×10^5^ PFU/ml ([Table 3](#pntd-0000472-t003){ref-type="table"}). Because the sera may not have been sampled at the time of peak viremia, these titers may underestimate maximum viremia levels.

10.1371/journal.pntd.0000472.t003

###### Viremia titers in febrile patients infected with VEEV.

![](pntd.0000472.t003){#pntd-0000472-t003-3}

  Code      Serum titer (PFU/ml)
  -------- ----------------------
  213413          2×10^2^
  213388          \<10^2^
  212857          7×10^3^
  212908         1.2×10^3^
  212860          \<10^2^
  213391         6.7×10^5^
  212863         2.0×10^4^

Phylogenetic analyses {#s3d}
---------------------

To investigate genetic relationships among the VEEV strains from Panama in comparison to others isolated from different regions of the Americas, phylogenetic analyses were performed. Maximum parsimony, neighbor joining and Bayesian methods all generated similar tree topologies. The neighbor-joining tree based on the partial PE2 sequences ([Figure 2](#pntd-0000472-g002){ref-type="fig"}) showed that most of the subtype ID VEEV strains from Panama formed a single clade, with previously sequenced Panamanian subtype ID strains as well as some Peruvian ID isolates. This group was previously called the Panama-Peru subtype ID genotype [@pntd.0000472-Oberste2]. Within this group, 2 distinct clades among the Panamanian strains were observed: 1) strains from Central Panama; 2) isolates from Eastern Panama (Darien). The final subtype ID isolate, strain 213391 from western Panama (Bocas del Toro Province), was phylogenetically distinct from all other ID isolates. Our phylogenies placed it outside of the Panama/Peru genotype, but this placement was supported by a bootstrap value of only 69%. The location of collection of this strain was geographically close to those of subtype IE strains isolated in the 1960s ([Fig. 2](#pntd-0000472-g002){ref-type="fig"}). Therefore, the geographic ranges of subtypes ID and IE may overlap slightly.

![Phylogenetic tree generated from partial PE2 gene sequences of Panamanian VEEV strains and homologous VEE complex alphavirus sequences from the GenBank library.\
The tree was produced using the neighbor joining program implemented in PAUP 4.0 [@pntd.0000472-Swofford1]. VEEV strains are denoted by abbreviated country and year of isolation, followed by strain designation. Panamanian strains include abbreviated province in parentheses as follows: BT -- Bocas del Toro; COC -- Cocle; COL -- Colon; DA -- Darien; PA -- Panama; VE -- Veraguas. Numbers indicate bootstrap values for clades.](pntd.0000472.g002){#pntd-0000472-g002}

Discussion {#s4}
==========

In 1961, the first evidence of VEEV in Panama was obtained when the virus was isolated from a fatal human case. The patient, a 14-year-old boy, resided in Cañito, near Gatun lake [@pntd.0000472-Johnson2]. Since then, febrile disease associated with VEEV has been reported in the vicinity of Gatun and Bayano Lakes and in the province of Darien, all areas of rainforest and swamp habitat. Our results indicate that VEEV infection in at least 2 regions of Panama may be common, and the clinical features of the disease evaluated in 33 acute individuals suggest that only laboratory diagnostics can distinguish VEE from other febrile, tropical diseases such as malaria, dengue and Mayaro fever that present with overlapping signs and symptoms. Thus, the incidence of VEE in Panama and other endemic regions of Latin America is probably grossly underreported because malaria and dengue are assumed to be the etiologies of all febrile illnesses in the absence of laboratory diagnostics. Because exposure to VEEV involves vectors with different temporal and spatial distributions than those of dengue and malaria [@pntd.0000472-Smith1],[@pntd.0000472-Weaver3], improved VEE diagnosis could lead to better prevention methods to reduce human exposure.

For subtype ID VEEV, the highest viremia titers that we measured in infected persons are presumably capable of orally infecting and being transmitted by several mosquito species including the proven subtype IE enzootic VEEV vector *Cx.* (*Mel.*) *taeniopus* [@pntd.0000472-Scherer1], and the proven and potential epidemic VEEV vectors *Psorophora confinnis* [@pntd.0000472-Ortiz1], *Ae. taeniorhynchus* [@pntd.0000472-Brault1],[@pntd.0000472-Ortiz2], *Ae. albopictus* [@pntd.0000472-Fernandez1] and *Ae. aegypti* [@pntd.0000472-Ortiz3]. Although infection thresholds have not been determined for natural, enzootic subtype ID vectors, we believe that it is likely that they could be infected by feeding on persons with titers on the order that we measured. Furthermore, serum titers and mosquito transmission potential could be even higher if the individuals we studied were not sampled at the peak of viremia. Previous studies have reported that horses infected with epidemic VEEV strains develop comparable viremia levels, which allow them to serve as highly efficient amplifying hosts by infecting susceptible mosquitoes [@pntd.0000472-Wang1],[@pntd.0000472-Walton2],[@pntd.0000472-Kissling1]. These results suggest the possibility that humans infected with subtype ID VEEV in Panama could support an epidemic human-mosquito-human transmission cycle, especially if a viremic individual reached an urban area with abundant *Ae. aegypti* or *Ae. albopictus*. These species, especially the former, are highly efficient vectors of other human arboviruses such as dengue [@pntd.0000472-Gubler1] and chikungunya [@pntd.0000472-Powers3] due to their ecology and behavior as well as their susceptibility to infection. Interestingly, VEE is endemic in Iquitos, Peru, where *Ae. aegypti* is abundant and transmits DENV to thousands of people during epidemics. However, the average number of diagnosed VEE human cases per year in Peru is about ten, but this is probably a gross underestimate of the true number (P.V. Aguilar, unpublished). Because VEEV viremia in humans is high enough to infect *Ae. aegypti*, regular human VEE outbreaks in Iquitos might be expected. However, only one VEE human outbreak has been reported in Iquitos (in 2006) [@pntd.0000472-Aguilar1] despite detection of endemic VEE there since 1993 [@pntd.0000472-Watts1]. Thus, additional factors not yet understood may be crucial to the emergence of enzootic VEE. Mutations that arise during the adaptation of the virus to certain mosquito species have been previously described as a key factor in the epizootic VEE emergence, and thus deserve further study [@pntd.0000472-Weaver1],[@pntd.0000472-Brault2]. Other factors such as mosquito abundance should also be investigated.

Hemorrhagic manifestations among VEE cases are rare. To date, only two patients (\<15 years of age) have been reported with hemorrhagic complications upon VEEV infection with the subtype ID Panama/Peru genotype [@pntd.0000472-Vilcarromero1]. Interestingly, one of the VEE patients from Panama that we studied also reported hemorrhagic manifestations and encephalitis, although the former was not determined to be the cause of death. Thus, although hemorrhages associated with VEEV infection are unusual, they do occur and their potential role in a fatal outcome should be investigated.

One of the Panamanian patients infected with VEEV from 1990--2004 developed a fatal encephalitic disease, further confirming that subtype ID Panama/Peru genotype can cause fatal disease. Although subtype ID Panama/Peru lineage strains have been continuously associated with human illness in Peru, fatal disease has never been reported there despite many cases in children [@pntd.0000472-Aguilar1]. The reasons for this lack of fatal VEE in Peru remain unknown, but could include underreporting in many locations where laboratory diagnosis is not readily available.

Our phylogenetic analyses revealed that all Panamanian isolates with one exception belong to the previously described Panama/Peru genotype [@pntd.0000472-Oberste2],[@pntd.0000472-Oberste3]. Within this group, 2 distinct clades among the Panamanian strains were observed: one sampled from Central Panama, and a second from Eastern Panama (Darien). A third Panamanian ID lineage was identified in western Panama (Bocas del Toro), which may represent a new, major lineage in subtype ID. Longer sequences may be needed to definitively determine the relationship of this new lineage to the other ID genotypes. Interestingly, this Bocas del Toro isolate was recovered from a patient who presented with encephalitis and hemorrhagic complications. Thus, further studies are needed to investigate whether this specific genotype is particularly associated with severe encephalitis and hemorrhagic disease. In addition, future genetic analyses of the Panamanian and Peruvian isolates associated with hemorrhagic disease could provide important insights about the viral determinants (if any) of this infrequent disease manifestation. Potential host factors/conditions should also be investigated for their role in disease outcome.
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